a public good project by the
Synthesis
Company
of California

© 2026

Merrill J. Egorin | doi.page

0 works0 citations0 h-index

Merrill J. Egorin

University of Pittsburgh(US)UPMC Hillman Cancer Center(US)

Publications by Year

Research Areas

Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Drug Transport and Resistance Mechanisms

Most-Cited Works

→ Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer(2009)3,106 cited
→ Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.(1995)560 cited
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.(2002)
→ Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08(2006)431 cited
→ Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.(1992)382 cited
→ Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme(2005)331 cited

→ A Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection(1992)

329 cited

→ High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?(1998)323 cited

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.(1984)

→ Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion(2000)297 cited